跳至主要内容
临床试验/NCT06892210
NCT06892210招募中4 期

Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Copenhagen Respiratory Research14 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2026年3月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
2,000
试验地点
14
主要终点
Readmission for COPD exacerbation or death from all causes

研究概览

简要总结

The goal of this cluster randomized controlled trial is to determine the optimal treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 40 years old diagnosed with chronic obstructive pulmonary disease with acute exacerbation. The main question is whether there is a difference in readmission for COPD excerbation or all cause mortality within thirty days.

Participants will randomized to receive treatment with either hydrocortisone or prednisolone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥40 years
  • •Chronic obstructive pulmonary disease with acute exacerbation, unspecified: ICDJ44

排除标准

  • •All diagnoses that would merit treatment with a specific corticosteroid
  • •Pregnant or breastfeeding women
  • •Active tuberculosis or invasive fungal infection

研究组 & 干预措施

Treatment with Hydrocortisone.

Active Comparator

This arm will recieve a dose of 200 mg of Hydrocortisone intravenously once daily for five days.

干预措施: Hydrocortisone (Drug)

Treatment with Methylprednisolone

Active Comparator

This arm will recieve a dose of 40 mg of Methylprednisolone intravenously once daily for five days.

干预措施: Methylprednisolone (drug) (Drug)

结局指标

主要结局

Readmission for COPD exacerbation or death from all causes

时间窗: 30 days

次要结局

  • Readmission for COPD exacerbation(90 days)
  • Daily amount of insulin administered to the patient by day 7 or discharge from hospital(7 days)
  • Gastrointestinal bleeding(30 days)
  • Days alive and out of hospital(14 days)
  • Mortality(90 days)
  • All-cause infections(90 days)
  • Need for mechanical ventilation(30 days)
  • New onset infections(30 days)
  • Blood glucose levels(7 days)

研究者

发起方
Copenhagen Respiratory Research
申办方类型
Network
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验